{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT02522052: Not Applicable Interventional Completed Rheumatoid Arthritis
(2015)
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
NCT04700527: Phase 1/Phase 2 Interventional Recruiting Toxicity
(2023)
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
NCT03095157: Not Applicable Interventional Unknown status Patients Scheduled for Thoracic Surgery/Esophagectomy Will be Enrolled
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
NCT03836404: Not Applicable Interventional Completed Bone Substitutes
(2019)
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
NCT01645254: Phase 1 Interventional Unknown status Malaria
(2012)
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
NCT00552773: Not Applicable Interventional Completed ACUTE SINUSITIS
(2007)
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
NCT04429295: Phase 3 Interventional Completed Pertussis Immunisation
(2020)
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
INN:velucovacap [INN]
Source URL:
Class:
G1 SPECIFIED SUBSTANCE
Status:
Investigational
Source:
INN:pegfosimer manganese [INN]
Source URL:
Class:
G1 SPECIFIED SUBSTANCE
Status:
Investigational
Source:
USAN:LUCORIDALINES [USAN]
Source URL:
Class:
G1 SPECIFIED SUBSTANCE
